FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

G V Doern

Research Profile

Procedures

Chemicals & Drugs

Living Beings

Physiology

Geographic Areas

United States

Disorders

Co-author Network

Publications

TOP 3
Philip Van De Griend; Loreen A Herwaldt; Bret Alvis; Mary DeMartino; Kristopher Heilmann; G V Doern; Patricia L Winokur; Diana DeSalvo Vonstein; Daniel Diekema
Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA.
Alan D Junkins; Shawn R Lockhart; Kristopher P Heilmann; Cassie L Dohrn; Diana L Von Stein; Patricia L Winokur; G V Doern; Sandra S Richter
BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin.
Stefan Riedel; Alan Junkins; Paul D Stamper; Gretchen Cress; John A Widness; G V Doern
Comparison of the Bactec 9240 and BacT/Alert blood culture systems for evaluation of placental cord blood for transfusion in neonates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of G V Doern (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Philip Van De Griend; Loreen A Herwaldt; Bret Alvis; Mary DeMartino; Kristopher Heilmann; G V Doern; Patricia L Winokur; Diana DeSalvo Vonstein; Daniel Diekema
Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA.
Emerging infectious diseases 2009;15(10):1582-9.
2009: Alan D Junkins; Shawn R Lockhart; Kristopher P Heilmann; Cassie L Dohrn; Diana L Von Stein; Patricia L Winokur; G V Doern; Sandra S Richter
BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin.
Journal of clinical microbiology 2009;47(9):2879-82.
2009: Stefan Riedel; Alan Junkins; Paul D Stamper; Gretchen Cress; John A Widness; G V Doern
Comparison of the Bactec 9240 and BacT/Alert blood culture systems for evaluation of placental cord blood for transfusion in neonates.
Journal of clinical microbiology 2009;47(6):1645-9.
2009: Lakshmi Durairaj; Zeinab Mohamad; Janice L Launspach; Alix Ashare; James Y Choi; Srinivasan Rajagopal; G V Doern; Joseph Zabner
Patterns and density of early tracheal colonization in intensive care unit patients.
Journal of critical care 2009;24(1):114-21.
2009: Sandra S Richter; Kristopher P Heilmann; Cassie L Dohrn; Fathollah Riahi; Susan E Beekmann; G V Doern
Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(3):e23-33.
2009: Benjamin W Darbro; Brian K Petroelje; G V Doern
Lactobacillus delbrueckii as the cause of urinary tract infection.
Journal of clinical microbiology 2009;47(1):275-7.
2008: Sandra S Richter; Kris P Heilmann; Cassie L Dohrn; Fathollah Riahi; Susan E Beekmann; G V Doern
Accuracy of phenotypic methods for identification of Streptococcus pneumoniae isolates included in surveillance programs.
Journal of clinical microbiology 2008;46(7):2184-8.
2008: Stefan Riedel; Paul Bourbeau; Brandi Swartz; Steven Brecher; Karen C Carroll; Paul D Stamper; W Michael Dunne; Timothy McCardle; Nathan Walk; Kristin Fiebelkorn; David Sewell; Sandra S Richter; Susan E Beekmann; G V Doern
Timing of specimen collection for blood cultures from febrile patients with bacteremia.
Journal of clinical microbiology 2008;46(4):1381-5.
2008: Sandra S Richter; Kris P Heilmann; Cassie L Dohrn; Susan E Beekmann; Fathollah Riahi; Juan Garcia-de-Lomas; Matus Ferech; Herman Goossens; G V Doern
Increasing telithromycin resistance among Streptococcus pyogenes in Europe.
The Journal of antimicrobial chemotherapy 2008;61(3):603-11.
2008: Michael E Pichichero; G V Doern; Joseph L Kuti; David P Nicolau
Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.
Paediatric drugs 2008;10(6):391-7.
2008: Renee M Fallon; Joseph L Kuti; G V Doern; Jennifer E Girotto; David P Nicolau
Pharmacodynamic target attainment of oral beta-lactams for the empiric treatment of acute otitis media in children.
Paediatric drugs 2008;10(5):329-35.
2007: Erik L Munson; G V Doern
Comparison of three commercial test systems for biotyping Haemophilus influenzae and Haemophilus parainfluenzae.
Journal of clinical microbiology 2007;45(12):4051-3.
2007: Shawn R Lockhart; Murray A Abramson; Susan E Beekmann; Gale Gallagher; Stefan Riedel; Daniel J Diekema; John P Quinn; G V Doern
Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.
Journal of clinical microbiology 2007;45(10):3352-9.
2007: Sandra S Richter; Wanita J Howard; Melvin P Weinstein; David A Bruckner; Janet F Hindler; Michael A Saubolle; G V Doern
Multicenter evaluation of the BD Phoenix Automated Microbiology System for antimicrobial susceptibility testing of Streptococcus species.
Journal of clinical microbiology 2007;45(9):2863-71.
2007: Stefan Riedel; Susan E Beekmann; Kris P Heilmann; Sandra S Richter; J Garcia-de-Lomas; M Ferech; H Goosens; G V Doern
Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(7):485-90.
2007: Stan L Block; G V Doern; Michael A Pfaller
Oral beta-lactams in the treatment of acute otitis media.
Diagnostic microbiology and infectious disease 2007;57(3 Suppl):19S-30S.
2007: Heather K Sun; Xiaoli Du; C Andrew DeRyke; G V Doern; David P Nicolau
parE mutations in Streptococcus pneumoniae may reduce bactericidal activity of respiratory fluoroquinolones.
International journal of antimicrobial agents 2007;29(2):230-2.
2007: Kathryn Eagye; David P Nicolau; Shawn R Lockhart; John P Quinn; G V Doern; Gale Gallagher; Murray A Abramson
A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the United States between 1993 and 2004.
Annals of clinical microbiology and antimicrobials 2007;6():11.
2006: Gregory C Gray; Ana W Capuano; Sharon F Setterquist; Dean D Erdman; Newell D Nobbs; Yacine Abed; G V Doern; Sarah E Starks; Guy Boivin
Multi-year study of human metapneumovirus infection at a large US Midwestern Medical Referral Center.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;37(4):269-76.
2006: G V Doern
Macrolide and ketolide resistance with Streptococcus pneumoniae.
The Medical clinics of North America 2006;90(6):1109-24.
2006: G V Doern
Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
Expert review of anti-infective therapy 2006;4(5):821-35.
2006: Stefan Riedel; Gregory Siwek; Susan E Beekmann; Sandra S Richter; Thomas J Raife; G V Doern
Comparison of the BACTEC 9240 and BacT/Alert blood culture systems for detection of bacterial contamination in platelet concentrates.
Journal of clinical microbiology 2006;44(6):2262-4.
2006: Susan E Beekmann; Daniel J Diekema; Kris P Heilmann; Sandra S Richter; G V Doern
Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2006;25(5):335-9.
2006: Glenn S Tillotson; G V Doern; Joseph M Blondeau
Optimal antimicrobial therapy: the balance of potency and exposure.
Expert opinion on investigational drugs 2006;15(4):335-7.
2006: Philip M Polgreen; Susan E Beekmann; Yi Yi Chen; G V Doern; Michael A Pfaller; Angela B Brueggemann; Loreen A Herwaldt; Daniel J Diekema
Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(3):252-6.
2006: Romolo J Gaspari; Eric W Dickson; James Karlowsky; G V Doern
Multidrug resistance in pediatric urinary tract infections.
Microbial drug resistance (Larchmont, N.Y.) 2006;12(2):126-9.
2005: Romolo J Gaspari; Eric W Dickson; James Karlowsky; G V Doern
Antibiotic resistance trends in paediatric uropathogens.
International journal of antimicrobial agents 2005;26(4):267-71.
2005: Sandra S Richter; Kris P Heilmann; Susan E Beekmann; Norma J Miller; Ashley L Miller; Cassie L Rice; Christopher D Doern; Sean D Reid; G V Doern
Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(5):599-608.
2005: G V Doern; Sandra S Richter; Ashley Miller; Norma Miller; Cassie Rice; Kris P Heilmann; Susan E Beekmann
Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(2):139-48.
2005: Susan E Beekmann; Daniel J Diekema; G V Doern
Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(6):559-66.
2005: Kris P Heilmann; Cassie L Rice; Ashley L Miller; Norma J Miller; Susan E Beekmann; Michael A Pfaller; Sandra S Richter; G V Doern
Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.
Antimicrobial agents and chemotherapy 2005;49(6):2561-4.
2005: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; G V Doern; Daniel J Diekema
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).
Journal of clinical microbiology 2005;43(5):2163-7.
2005: Susan E Beekmann; Kris P Heilmann; Sandra S Richter; Juan García-de-Lomas; G V Doern
Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
International journal of antimicrobial agents 2005;25(2):148-56.
2005: Sandra S Richter; Kris P Heilmann; Susan E Beekmann; Norma J Miller; Cassie L Rice; G V Doern
The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(2):225-35.
2005: G V Doern
Antimicrobial resistance with bacterial causes of community-acquired respiratory tract infections in the United States.
Treatments in respiratory medicine 2005;4 Suppl 1():1-4.
2004: P G Ambrose; D Bast; G V Doern; P B Iannini; Ronald Jones; keith klugman; Donald E Low
Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(10):1554-6; author reply 1556-7.
2004: Erik L Munson; Stephen O Heard; G V Doern
In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistance.
Chest 2004;126(5):1628-35.
2004: Daniel J Diekema; Kathleen Lee; Patti Raney; Loreen A Herwaldt; G V Doern; Fred C Tenover
Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures.
Journal of clinical microbiology 2004;42(5):2258-60.
2004: G V Doern; Steve D Brown
Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01.
The Journal of infection 2004;48(1):56-65.
2003: Eric W Dickson; G V Doern; Leo Trevino; Michelle Mazzoni; Stephen O Heard
Prevention of descending pneumonia in rts with perflubron-delivered tobramycin.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2003;10(10):1019-23.
2003: Daniel J Diekema; Susan E Beekmann; Kimberle C Chapin; K A Morel; Erik L Munson; G V Doern
Epidemiology and outcome of nosocomial and community-onset bloodstream infection.
Journal of clinical microbiology 2003;41(8):3655-60.
2003: Susan E Beekmann; Daniel J Diekema; Kimberle C Chapin; G V Doern
Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges.
Journal of clinical microbiology 2003;41(7):3119-25.
2003: Sandra S Richter; D E Kealey; C T Murray; Kris P Heilmann; Stacy Coffman; G V Doern
The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species.
The Journal of antimicrobial chemotherapy 2003;52(1):123-7.
2003: Sherene S Min; David J Weber; Brian J Donovan; Peter H Gilligan; Bruce A Cairns; G V Doern; William A Rutala
Multidrug-resistant Enterococcus faecium in a patient with burns.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(9):1210-1.
2003: Michael E Klepser; Donald G Klepser; Erika J Ernst; John Brooks; Daniel J Diekema; Essy Mozaffari; Joseph Hendrickson; G V Doern
Health care resource utilization associated with treatment of penicillin-susceptible and -nonsusceptible isolates of Streptococcus pneumoniae.
Pharmacotherapy 2003;23(3):349-59.
2003: Holly L Hoffman; Michael E Klepser; Erika J Ernst; C Rosemarie Petzold; Loai Mohammed Sa'adah; G V Doern
Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model.
Antimicrobial agents and chemotherapy 2003;47(2):739-46.
2003: Sandra S Richter; Daniel J Diekema; Kris P Heilmann; Laurel S Almer; Virginia D Shortridge; Rod Zeitler; Robert K Flamm; G V Doern
Fluoroquinolone resistance in Streptococcus pyogenes.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(3):380-3.
2003: Erik L Munson; Daniel J Diekema; Susan E Beekmann; Kimberle C Chapin; G V Doern
Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management.
Journal of clinical microbiology 2003;41(1):495-7.
2002: G V Doern
Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2002;127(6 Suppl):S17-23.
2002: Erik L Munson; Michael A Pfaller; G V Doern
Modification of dienes mutual inhibition test for epidemiological characterization of Pseudomonas aeruginosa isolates.
Journal of clinical microbiology 2002;40(11):4285-8.
2002: Sandra S Richter; Susan E Beekmann; J L Croco; Daniel J Diekema; FP Koontz; Michael A Pfaller; G V Doern
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm.
Journal of clinical microbiology 2002;40(7):2437-44.
2002: Erika J Ernst; Michael E Klepser; C Rosemarie Petzold; G V Doern
Evaluation of survival and pharmacodynamic relationships for five fluoroquinolones in a neutropenic murine model of pneumococcal lung infection.
Pharmacotherapy 2002;22(4):463-70.
2002: Daniel J Diekema; Shawn A Messer; Angela B Brueggemann; Stacy Coffman; G V Doern; Loreen A Herwaldt; Michael A Pfaller
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.
Journal of clinical microbiology 2002;40(4):1298-302.
2002: Erik L Munson; Michael A Pfaller; FP Koontz; G V Doern
Comparison of porphyrin-based, growth factor-based, and biochemical-based testing methods for identification of Haemophilus influenzae.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(3):196-203.
2002: Angela B Brueggemann; Stacy Coffman; Paul R Rhomberg; Holly Huynh; Laurel S Almer; Angela M Nilius; Robert K Flamm; G V Doern
Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.
Antimicrobial agents and chemotherapy 2002;46(3):680-8.
2002: Eric W Dickson; Stephen O Heard; Thomas E Tarara; Jeffry G Weers; Angela B Brueggemann; G V Doern
Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumonia.
Critical care medicine 2002;30(2):393-5.
2002: Sandra S Richter; Kris P Heilmann; Stacy Coffman; HK Huynh; Angela B Brueggemann; Michael A Pfaller; G V Doern
The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(3):330-9.
2001: D M Musher; John G Bartlett; G V Doern
A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics.
Archives of internal medicine 2001;161(21):2538-44.
2001: Patricia L Winokur; D L Vonstein; L J Hoffman; E K Uhlenhopp; G V Doern
Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans.
Antimicrobial agents and chemotherapy 2001;45(10):2716-22.
2001: G V Doern
Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33 Suppl 3():S187-92.
2001: G V Doern
Antimicrobial resistance with Streptococcus pneumoniae: much ado about nothing?
Seminars in respiratory infections 2001;16(3):177-85.
2001: G V Doern; G S Tillotson
Fluoroquinolone pharmacodynamics and efficacy.
Chest 2001;120(1):319-20.
2001: Sanjai Nagendra; P Bourbeau; S Brecher; M Dunne; M LaRocco; G V Doern
Sampling variability in the microbiological evaluation of expectorated sputa and endotracheal aspirates.
Journal of clinical microbiology 2001;39(6):2344-7.
2001: G V Doern; Kris P Heilmann; HK Huynh; Paul R Rhomberg; Stacy Coffman; Angela B Brueggemann
Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.
Antimicrobial agents and chemotherapy 2001;45(6):1721-9.
2001: Daryl J Hoban; G V Doern; A C Fluit; M Roussel-Delvallez; Ronald Jones
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S81-93.
2001: W Michael Dunne; K S Kehl; C A Holland-Staley; AB Brueggemann; Michael A Pfaller; G V Doern
Comparison of results generated by serotyping, pulsed-field restriction analysis, ribotyping, and repetitive-sequence PCR used to characterize penicillin-resistant pneumococci from the United States.
Journal of clinical microbiology 2001;39(5):1791-5.
2001: Michael E Klepser; Erika J Ernst; C Rosemarie Petzold; Paul R Rhomberg; G V Doern
Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
Antimicrobial agents and chemotherapy 2001;45(3):673-8.
2001: Angela B Brueggemann; Michael A Pfaller; G V Doern
Use of penicillin MICs to predict in vitro activity of other beta-lactam antimicrobial agents against Streptococcus pneumoniae.
Journal of clinical microbiology 2001;39(1):367-9.
2000: A B Brueggemann; G V Doern
Resistance among Streptococcus pneumoniae: patterns, mechanisms, interpreting the breakpoints.
The American journal of managed care 2000;6(23 Suppl):S1189-96.
2000: Janet I Andrews; Daniel J Diekema; Stephen K Hunter; Paul R Rhomberg; Michael A Pfaller; Ronald Jones; G V Doern
Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.
American journal of obstetrics and gynecology 2000;183(4):859-62.
2000: Patricia L Winokur; Angela B Brueggemann; D L DeSalvo; L Hoffmann; M D Apley; E K Uhlenhopp; Michael A Pfaller; G V Doern
Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.
Antimicrobial agents and chemotherapy 2000;44(10):2777-83.
2000: Daniel J Diekema; Angela B Brueggemann; G V Doern
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.
Emerging infectious diseases 2000;6(5):552-6.
2000: Ana Gales; Ronald Jones; Kelley A Gordon; Helio S Sader; Werner W Wilke; Mondell L Beach; Michael A Pfaller; G V Doern
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
The Journal of antimicrobial chemotherapy 2000;45(3):295-303.
2000: Michael A Pfaller; I Mujeeb; Richard J Hollis; Ronald Jones; G V Doern
Evaluation of the discriminatory powers of the Dienes test and ribotyping as typing methods for Proteus mirabilis.
Journal of clinical microbiology 2000;38(3):1077-80.
2000: Michael A Pfaller; Ronald Jones; G V Doern; Helio S Sader; Shawn A Messer; AK Houston; Stacy Coffman; Richard J Hollis
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.
Antimicrobial agents and chemotherapy 2000;44(3):747-51.
2000: Daniel J Diekema; Michael A Pfaller; Ronald Jones; G V Doern; KC Kugler; Mondell L Beach; Helio S Sader
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.
International journal of antimicrobial agents 2000;13(4):257-71.
2000: Angela B Brueggemann; G V Doern; HK Huynh; EM Wingert; Paul R Rhomberg
In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Antimicrobial agents and chemotherapy 2000;44(2):447-9.
2000: Sandra S Richter; Patricia L Winokur; Angela B Brueggemann; HK Huynh; Paul R Rhomberg; EM Wingert; G V Doern
Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.
Antimicrobial agents and chemotherapy 2000;44(2):444-6.
2000: G V Doern
Antimicrobial resistance with Streptococcus pneumoniae in the United States.
Seminars in respiratory and critical care medicine 2000;21(4):273-84.
2000: Daniel J Diekema; Michael A Pfaller; J Turnidge; Jan Verhoef; J Bell; A C Fluit; G V Doern; Ronald Jones
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998.
Microbial drug resistance (Larchmont, N.Y.) 2000;6(3):213-21.
2000: G V Doern
Detection of selected fastidious bacteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(1):166-73.
1999: Michael A Pfaller; Ronald Jones; G V Doern; Juan C Salazar
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Diagnostic microbiology and infectious disease 1999;35(3):235-41.
1999: G V Doern; Angela B Brueggemann; Holly Huynh; EM Wingert
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
Emerging infectious diseases 1999;5(6):757-65.
1999: Virginia D Shortridge; G V Doern; A B Brueggemann; Jill M Beyer; Robert K Flamm
Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(5):1186-8.
1999: Sandra S Richter; Angela B Brueggemann; HK Huynh; Paul R Rhomberg; EM Wingert; Robert K Flamm; G V Doern
A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions.
International journal of antimicrobial agents 1999;13(2):99-107.
1999: Michael A Pfaller; Ronald Jones; G V Doern
Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest method. Venezuelan Antimicrobial Resistance Study Group.
Diagnostic microbiology and infectious disease 1999;35(2):153-8.
1999: Daniel J Diekema; Michael A Pfaller; Ronald Jones; G V Doern; Patricia L Winokur; Ana Gales; Helio S Sader; KC Kugler; M Beach
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(3):595-607.
1999: BJ Buschelman; Ronald Jones; Michael A Pfaller; FP Koontz; G V Doern
Colony morphology of Candida spp. as a guide to species identification.
Diagnostic microbiology and infectious disease 1999;35(1):89-91.
1999: Michael A Pfaller; V Korten; Ronald Jones; G V Doern
Multicenter evaluation of the antimicrobial activity for seven broad-spectrum beta-lactams in Turkey using the Etest method. Turkish Antimicrobial Resistance Study Group.
Diagnostic microbiology and infectious disease 1999;35(1):65-73.
1999: Michael A Pfaller; Ronald Jones; G V Doern; A C Fluit; Jan Verhoef; Helio S Sader; Shawn A Messer; AK Houston; Stacy Coffman; Richard J Hollis
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).
Diagnostic microbiology and infectious disease 1999;35(1):19-25.
1999: Daniel J Diekema; Michael A Pfaller; Shawn A Messer; AK Houston; Richard J Hollis; G V Doern; Ronald Jones
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.
Antimicrobial agents and chemotherapy 1999;43(9):2236-9.
1999: Timothy F Murphy; Sanjay Sethi; K L Klingman; Angela B Brueggemann; G V Doern
Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy.
The Journal of infectious diseases 1999;180(2):404-9.
1999: G V Doern; Ronald Jones; Michael A Pfaller; KC Kugler; Mondell L Beach
Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America).
Diagnostic microbiology and infectious disease 1999;34(1):65-72.
1999: G V Doern; Angela B Brueggemann; Michael A Pfaller; Ronald Jones
Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: a report from the College of American Pathologists Microbiology Proficiency Survey Program.
Archives of pathology & laboratory medicine 1999;123(4):285-9.
1999: Michael A Pfaller; Ronald Jones; G V Doern; Helio S Sader; KC Kugler; Mondell L Beach
Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group.
Diagnostic microbiology and infectious disease 1999;33(4):283-97.
1999: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Ronald Jones; G V Doern; Mary E Brandt; RA Hajjeh
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.
Diagnostic microbiology and infectious disease 1999;33(4):217-22.
1999: G V Doern; Ronald Jones; Michael A Pfaller; KC Kugler
Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997).
Antimicrobial agents and chemotherapy 1999;43(2):385-9.
1998: G V Doern; Michael A Pfaller; ME Erwin; Angela B Brueggemann; Ronald Jones
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program.
Diagnostic microbiology and infectious disease 1998;32(4):313-6.
1998: Helio S Sader; Ronald Jones; Ana Gales; Patricia L Winokur; KC Kugler; Michael A Pfaller; G V Doern
Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.
Diagnostic microbiology and infectious disease 1998;32(4):289-301.
1998: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Ronald Jones; G V Doern; Mary E Brandt; RA Hajjeh
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole.
Antimicrobial agents and chemotherapy 1998;42(12):3242-4.
1998: Ronald Jones; Mondell L Beach; Michael A Pfaller; G V Doern
Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America.
Diagnostic microbiology and infectious disease 1998;32(3):247-52.
1998: MA Croco; Douglas J Biedenbach; Michael A Pfaller; G V Doern; Ronald Jones
In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.
The Journal of antimicrobial chemotherapy 1998;42(5):672-3.
1998: J R DiPersio; Ronald Jones; T Barrett; G V Doern; Michael A Pfaller
Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: report from the SENTRY Antimicrobial Surveillance Program (1998).
Diagnostic microbiology and infectious disease 1998;32(2):131-5.
1998: Ronald Jones; Michael A Pfaller; G V Doern
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.
Diagnostic microbiology and infectious disease 1998;32(2):119-26.
1998: Ronald Jones; Douglas J Biedenbach; SA Marshall; Michael A Pfaller; G V Doern
Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime.
Diagnostic microbiology and infectious disease 1998;32(2):107-10.
1998: G V Doern; Michael A Pfaller; KC Kugler; J Freeman; Ronald Jones
Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(4):764-70.
1998: G V Doern; AB Brueggemann; Michael Blocker; M Dunne; H P Holley; K S Kehl; J Duval; K Kugler; Shan Putnam; A Rauch; Michael A Pfaller
Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(4):757-61.
1998: Y S Chen; SA Marshall; Patricia L Winokur; Stacy Coffman; Werner W Wilke; P R Murray; C A Spiegel; Michael A Pfaller; G V Doern; Ronald Jones
Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci.
Journal of clinical microbiology 1998;36(10):2996-3001.
1998: G V Doern; A Barton; S Rao
Controlled comparative evaluation of BacT/Alert FAN and ESP 80A aerobic media as means for detecting bacteremia and fungemia.
Journal of clinical microbiology 1998;36(9):2686-9.
1998: J P Brinker; G V Doern
Enhancement of varicella-zoster virus detection in A-549 shell vials by use of freeze-thawed specimens, extended incubation, and "a centrifuged, not incubated" direct detection method.
Diagnostic microbiology and infectious disease 1998;31(4):555-8.
1998: Michael A Pfaller; Ronald Jones; G V Doern; KC Kugler
Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).
Antimicrobial agents and chemotherapy 1998;42(7):1762-70.
1998: Michael A Pfaller; Ronald Jones; G V Doern; Helio S Sader; Richard J Hollis; Shawn A Messer
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
Journal of clinical microbiology 1998;36(7):1886-9.
1998: M M Bergman; D Gagnon; G V Doern
Pichia ohmeri fungemia.
Diagnostic microbiology and infectious disease 1998;30(3):229-31.
1998: Ronald Jones; Michael A Pfaller; G V Doern; ME Erwin; Richard J Hollis
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
Diagnostic microbiology and infectious disease 1998;30(3):215-28.
1998: G V Doern; Ronald Jones; Michael A Pfaller; ME Erwin; C Ramirez-Rhonda
Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group.
Diagnostic microbiology and infectious disease 1998;30(2):113-9.
1998: Stephen O Heard; M Wagle; E Vijayakumar; S McLean; Angela B Brueggemann; Lena M Napolitano; L P Edwards; FM O'Connell; Juan Carlos Puyana; G V Doern
Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.
Archives of internal medicine 1998;158(1):81-7.
1998: Michael A Pfaller; Ronald Jones; G V Doern
Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group.
Diagnostic microbiology and infectious disease 1998;30(1):45-52.
1998: Eric W Dickson; Stephen O Heard; B Chu; Armando E Fraire; Angela B Brueggemann; G V Doern
Partial liquid ventilation with perfluorocarbon in the treatment of rats with lethal pneumococcal pneumonia.
Anesthesiology 1998;88(1):218-23.
1997: Ronald Jones; Juan C Salazar; Michael A Pfaller; G V Doern
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Diagnostic microbiology and infectious disease 1997;29(4):265-72.
1997: G V Doern; AB Brueggemann; R Perla; J Daly; D Halkias; Ronald Jones; M A Saubolle
Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa.
Journal of clinical microbiology 1997;35(8):2115-9.
1997: AB Brueggemann; K C Kugler; G V Doern
In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Antimicrobial agents and chemotherapy 1997;41(7):1594-7.
1997: G V Doern; L Robbie; R St Amand
Comparison of the Vidas and Bio-Whittaker enzyme immunoassays for detecting IgG reactive with varicella-zoster virus and mumps virus.
Diagnostic microbiology and infectious disease 1997;28(1):31-4.
1997: G V Doern; AB Brueggemann; W Michael Dunne; S G Jenkins; D C Halstead; J C McLaughlin
Four-day incubation period for blood culture bottles processed with the Difco ESP blood culture system.
Journal of clinical microbiology 1997;35(5):1290-2.
1997: G V Doern; AB Brueggemann; G Pierce
Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(4):311-4.
1997: G V Doern; AB Brueggemann; G Pierce; H P Holley; A Rauch
Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
Antimicrobial agents and chemotherapy 1997;41(2):292-7.
1996: G V Doern; A B Brueggemann; G Pierce; T Hogan; H P Holley; A Rauch
Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.
Antimicrobial agents and chemotherapy 1996;40(12):2884-6.
1996: G V Doern; G Pierce; A B Brueggemann
In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Diagnostic microbiology and infectious disease 1996;26(1):39-42.
1996: SA Marshall; Ronald Jones; A Wanger; JA Washington; G V Doern; A L Leber; T H Haugen
Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin.
Journal of clinical microbiology 1996;34(8):2027-9.
1996: G V Doern
Diagnostic mycobacteriology: where are we today?
Journal of clinical microbiology 1996;34(8):1873-6.
1996: DM Johnson; G V Doern; T A Haugen; J Hindler; JA Washington; Ronald Jones
Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests.
Diagnostic microbiology and infectious disease 1996;25(3):137-41.
1996: G V Doern; B B Torres; M Jankins; Ronald Jones
Accurate characterization of ofloxacin susceptibility with Enterobacteriaceae using a modified GNS F6 card and the bioMerieux Vitek System.
Diagnostic microbiology and infectious disease 1996;25(3):133-5.
1996: G V Doern
Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group.
The Journal of antimicrobial chemotherapy 1996;38 Suppl A():59-69.
1996: G V Doern; A Brueggemann; H P Holley; A M Rauch
Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.
Antimicrobial agents and chemotherapy 1996;40(5):1208-13.
1996: G V Doern; M J Ferraro; A B Brueggemann; Kathryn L Ruoff
Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.
Antimicrobial agents and chemotherapy 1996;40(4):891-4.
1996: G V Doern; R Davaro; M George; P Campognone
Lack of requirement for prolonged incubation of Septi-Chek blood culture bottles in patients with bacteremia due to fastidious bacteria.
Diagnostic microbiology and infectious disease 1996;24(3):141-3.
1995: G V Doern
Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract.
The American journal of medicine 1995;99(6B):3S-7S.
1995: G V Doern
Battle against bacteria shifts focus. Interview by William A. Check.
CAP today / College of American Pathologists 1995;9(12):1, 12-5, 18-9.
1995: A L Barton; G V Doern
Selective media for detecting gastrointestinal carriage of vancomycin-resistant enterococci.
Diagnostic microbiology and infectious disease 1995;23(3):119-22.
1995: G V Doern; Ronald Jones; E H Gerlach; J A Washington; D J Biedenbach; A Brueggemann; ME Erwin; C Knapp; J Raymond
Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1.
Journal of clinical microbiology 1995;33(6):1665-7.
1995: G V Doern
Resistance among problem respiratory pathogens in pediatrics.
The Pediatric infectious disease journal 1995;14(5):420-3.
1995: G V Doern
The in vitro activity of cefotaxime versus bacteria involved in selected infections of hospitalized patients outside of the intensive care unit.
Diagnostic microbiology and infectious disease 1995;22(1-2):13-7.
1995: A E Fraire; G V Doern
Invasive aspergillosis in a patient with bronchocentric granulomatosis.
Journal of intensive care medicine 1995;10(1):3-4.
1994: G V Doern; L Robbie; L Marrama
Comparison of two enzyme immunoassays and two latex agglutination assays for detection of cytomegalovirus antibody.
Diagnostic microbiology and infectious disease 1994;20(2):109-12.
1994: G V Doern; J A Westerling
Optimum recovery of Mycobacterium avium complex from blood specimens of human immunodeficiency virus-positive patients by using small volumes of isolator concentrate inoculated into BACTEC 12B bottles.
Journal of clinical microbiology 1994;32(10):2576-7.
1994: G V Doern; R Vautour; M Gaudet; B Levy
Clinical impact of rapid in vitro susceptibility testing and bacterial identification.
Journal of clinical microbiology 1994;32(7):1757-62.
1994: G V Doern; Ronald Jones; E H Gerlach; J Hindler; R St Amand
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(6):481-9.
1994: Ronald Jones; G V Doern; E H Gerlach; J Hindler; ME Erwin
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
Diagnostic microbiology and infectious disease 1994;18(4):243-9.
1994: G V Doern
Manual blood culture systems and the antimicrobial removal device.
Clinics in laboratory medicine 1994;14(1):133-47.
1993: A R Mattia; G V Doern; J Clark; J Holden; L Wu; M J Ferraro
Comparison of four methods in the diagnosis of Clostridium difficile disease.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(11):882-6.
1993: J P Brinker; G V Doern
Comparison of MRC-5 and A-549 cells in conventional culture tubes and shell vial assays for the detection of varicella-zoster virus.
Diagnostic microbiology and infectious disease 1993;17(1):75-7.
1993: G V Doern; Ronald Jones
In vitro susceptibility test practices with Haemophilus influenzae among College of American Pathologists survey participants in the United States.
Diagnostic microbiology and infectious disease 1993;17(1):61-5.
1993: G V Doern
The role of the clinical microbiology laboratory and the clinical pharmacy in the management of infectious disease (ASM, 1992). Introduction.
Diagnostic microbiology and infectious disease 1993;16(3):227-9.
1993: Gordon L Archer; P Auger; G V Doern; M J Ferraro; P C Fuchs; James Jorgensen; Donald E Low; P R Murray; L B Reller; C W Stratton
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci.
Diagnostic microbiology and infectious disease 1993;16(3):223-6.
1993: G V Doern; R Vautour
Impact of intervention on the frequency with which leaky urine specimens are received in the laboratory.
Diagnostic microbiology and infectious disease 1993;16(2):141-3.
1992: G V Doern
In vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations.
Journal of clinical microbiology 1992;30(12):3035-8.
1992: J P Brinker; G V Doern
A comparison of commercially available monoclonal antibodies for direct and indirect immunofluorescence culture confirmation and direct detection of parainfluenza viruses.
Diagnostic microbiology and infectious disease 1992;15(8):669-72.
1992: G V Doern; B Brogden-Torres
Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.
Journal of clinical microbiology 1992;30(10):2740-2.
1992: G V Doern; R Vautour
In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
Diagnostic microbiology and infectious disease 1992;15(7):633-40.
1992: G V Doern; R T Coughlin; L Wu
Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays.
Journal of clinical microbiology 1992;30(8):2042-6.
1992: James Jorgensen; A L Barry; G V Doern; M J Ferraro; P R Murray
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.
Journal of clinical microbiology 1992;30(8):2029-32.
1992: James Jorgensen; G V Doern; M J Ferraro; C C Knapp; J M Swenson; J A Washington
Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits.
Journal of clinical microbiology 1992;30(4):961-6.
1992: Charles L Shapiro; R F Haft; N M Gantz; G V Doern; John C Christenson; R O'Brien; J C Overall; B A Brown; R J Wallace
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(1):200-3.
1991: G V Doern; E H Gerlach; James Jorgensen; P R Murray; C Thornsberry; J A Washington
Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium.
Diagnostic microbiology and infectious disease 1991;14(6):485-93.
1991: G V Doern; R Vautour; D Parker; T Tubert; B Torres
In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis.
Antimicrobial agents and chemotherapy 1991;35(7):1504-7.
1991: G V Doern
In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
Diagnostic microbiology and infectious disease 1991;14(1):75-7.
1990: Isabelle Joris; H F Cuénoud; G V Doern; J M Underwood; G Majno
Capillary leakage in inflammation. A study by vascular labeling.
The American journal of pathology 1990;137(6):1353-63.
1990: James Jorgensen; G V Doern; L A Maher; A W Howell; J S Redding
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.
Antimicrobial agents and chemotherapy 1990;34(11):2075-80.
1990: G V Doern; T A Tubert
In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
Diagnostic microbiology and infectious disease 1990;13(4):349-52.
1990: G V Doern
Branhamella catarrhalis: phenotypic characteristics.
The American journal of medicine 1990;88(5A):33S-35S.
1990: G V Doern; James Jorgensen; C Thornsberry; H Snapper
Disk diffusion susceptibility testing of Haemophilus influenzae using haemophilus test medium.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(5):329-36.
1989: Mitchell Fink; C M Helsmoortel; E J Arous; G V Doern; K P Moriarty; P G Fairchild; P L Townsend
Comparison of the safety and efficacy of parenteral ticarcillin/clavulanate and clindamycin/gentamicin in serious intra-abdominal infections.
The Journal of antimicrobial chemotherapy 1989;24 Suppl B():147-56.
1988: G V Doern; Ronald Jones
Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.
Antimicrobial agents and chemotherapy 1988;32(12):1747-53.
1988: Frederick J Curley; Richard S Irwin; M R Pratter; D H Stivers; G V Doern; P A Vernaglia; A B Larkin; Stephen Baker
Cough and the common cold.
The American review of respiratory disease 1988;138(2):305-11.
1988: J Wüst; G V Doern; A von Graevenitz
Branhamella catarrhalis: fatty acid and lipopolysaccharide analysis of an atypical strain from blood culture.
Diagnostic microbiology and infectious disease 1988;10(2):131-4.
1988: A R Russo; S L Stone; Mary-Ellen Taplin; H J Snapper; G V Doern
Presumptive evidence for Blastocystis hominis as a cause of colitis.
Archives of internal medicine 1988;148(5):1064.
1988: G V Doern; James Jorgensen; C Thornsberry; D A Preston; T Tubert; J S Redding; L A Maher
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.
Antimicrobial agents and chemotherapy 1988;32(2):180-5.
1988: G V Doern; T A Tubert
In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods.
Antimicrobial agents and chemotherapy 1988;32(2):259-61.
1988: James Jorgensen; G V Doern; C Thornsberry; D A Preston; J S Redding; L A Maher; T Tubert
Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.
Diagnostic microbiology and infectious disease 1988;9(1):27-32.
1987: G V Doern; T Tubert
Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents.
Antimicrobial agents and chemotherapy 1987;31(10):1519-23.
1987: G V Doern; G S Daum; T A Tubert
Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae.
Journal of clinical microbiology 1987;25(9):1675-8.
1987: G V Doern; T Tubert
Effect of inoculum size on results of macrotube broth dilution susceptibility tests with Branhamella catarrhalis.
Journal of clinical microbiology 1987;25(8):1576-8.
1987: G V Doern; K C Chapin
Determination of biotypes of Haemophilus influenzae and Haemophilus parainfluenzae a comparison of methods and a description of a new biotype (VIII) of H. parainfluenzae.
Diagnostic microbiology and infectious disease 1987;7(4):269-72.
1987: G V Doern; G S Daum; T A Tubert
In vitro chloramphenicol susceptibility testing of Haemophilus influenzae: disk diffusion procedures and assays for chloramphenicol acetyltransferase.
Journal of clinical microbiology 1987;25(8):1453-5.
1987: G V Doern; T A Tubert
Detection of beta-lactamase activity among clinical isolates of Branhamella catarrhalis with six different beta-lactamase assays.
Journal of clinical microbiology 1987;25(8):1380-3.
1987: G V Doern; J L Staneck; C Needham; T Tubert
Sensititre autoreader for same-day breakpoint broth microdilution susceptibility testing of members of the family Enterobacteriaceae.
Journal of clinical microbiology 1987;25(8):1481-5.
1986: G V Doern; T A Tubert; K Chapin; M G Rinaldi
Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
Journal of clinical microbiology 1986;24(4):507-11.
1986: G V Doern; M A Saubolle; D L Sewell
Screening for bacteriuria with the LN strip test.
Diagnostic microbiology and infectious disease 1986;4(4):355-8.
1986: G V Doern
Clinically expedient reporting of rapid diagnostic test information.
Diagnostic microbiology and infectious disease 1986;4(3 Suppl):151S-156S.
1986: G V Doern
Branhamella catarrhalis--an emerging human pathogen.
Diagnostic microbiology and infectious disease 1986;4(3):191-201.
1986: G V Doern; James Jorgensen; C Thornsberry; D A Preston
Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.
Diagnostic microbiology and infectious disease 1986;4(2):95-107.
1986: G V Doern; John E Herrmann; P Henderson; D Stobbs-Walro; D M Perron; NR Blacklow
Detection of rotavirus with a new polyclonal antibody enzyme immunoassay (Rotazyme II) and a commercial latex agglutination test (Rotalex): comparison with a monoclonal antibody enzyme immunoassay.
Journal of clinical microbiology 1986;23(2):226-9.
1986: G V Doern; K C Chapin
Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
Diagnostic microbiology and infectious disease 1986;4(1):37-41.
1985: G V Doern
Clinical impact of rapid susceptibility testing.
Diagnostic microbiology and infectious disease 1985;3(6 Suppl):59S-64S.
1985: T G DeWitt; K F Humphrey; G V Doern
White blood cell counts in patients with Campylobacter-induced diarrhea and in controls.
The Journal of infectious diseases 1985;152(2):427-8.
1985: G V Doern; A Dascal; M Keville
Susceptibility testing with the sensititer breakpoint broth microdilution system.
Diagnostic microbiology and infectious disease 1985;3(3):185-91.
1984: M W Keville; G V Doern
Evaluation of the DMS Rapid E system for identification of clinical isolates of the family Enterobacteriaceae.
Journal of clinical microbiology 1984;20(5):1010-1.
1984: N M Gantz; G M Presswood; R Goldberg; G V Doern
Effects of dressing type and change interval on intravenous therapy complication rates.
Diagnostic microbiology and infectious disease 1984;2(4):325-32.
1984: G V Doern; K C Chapin
Laboratory identification of Haemophilus influenzae: effects of basal media on the results of the satellitism test and evaluation of the RapID NH system.
Journal of clinical microbiology 1984;20(3):599-601.
1984: S H Cheeseman; G V Doern; R A Ferriani; M W Keville; B R McGraw; J A Stewart
Detection of cytomegalovirus antibody with two commercially available assays, an indirect hemagglutination test and an enzyme immunosorbent assay.
Journal of clinical microbiology 1984;20(1):9-11.
1983: G V Doern; N M Gantz
Detection of bacteremia in patients receiving antimicrobial therapy: an evaluation of the antimicrobial removal device and 16B medium.
Journal of clinical microbiology 1983;18(1):43-8.
1983: K C Chapin; G V Doern
Selective media for recovery of Haemophilus influenzae from specimens contaminated with upper respiratory tract microbial flora.
Journal of clinical microbiology 1983;17(6):1163-5.
1983: G V Doern; J E Earls; P A Jeznach; D S Parker
Species identification and biotyping of staphylococci by the API staph-ident system.
Journal of clinical microbiology 1983;17(2):260-3.
1982: G V Doern; L I Robbie
Direct identification of Staphylococcus aureus in blood culture fluid with a commercial latex agglutination test.
Journal of clinical microbiology 1982;16(6):1048-51.
1982: G V Doern; B E Brogden; J D DiFederico; J E Earls; M L Quinn
Quantitative microbiological monitoring of hemodialysis fluids: evaluation of methods and demonstration of lack of test relevance in single-pass hemodialysis machines with automatic dialysate proportioning with reverse osmosis-treated tap water.
Journal of clinical microbiology 1982;16(6):1025-9.
1982: G V Doern; N M Gantz
Isolation of Branhamella (Neisseria) catarrhalis from men with urethritis.
Sexually transmitted diseases 1982;9(4):202-4.
1982: G V Doern; NR Blacklow; N M Gantz; P Aucoin; R A Fischer; D S Parker
Neisseria sicca osteomyelitis.
Journal of clinical microbiology 1982;16(3):595-7.
1982: M W Keville; G V Doern
Comparison of the API 20S Streptococcus identification system with an immunorheophoresis procedure and two commercial latex agglutination tests for identifying beta-hemolytic streptococci.
Journal of clinical microbiology 1982;16(1):92-5.
1982: G V Doern; D R Scott; A L Rashad
Clinical impact of rapid antimicrobial susceptibility testing of blood culture isolates.
Antimicrobial agents and chemotherapy 1982;21(6):1023-4.
1982: G V Doern
Evaluation of a commercial latex agglutination test for identification of Staphylococcus aureus.
Journal of clinical microbiology 1982;15(3):416-8.
1981: G V Doern; D R Scott; A L Rashad; K S Kim
Evaluation of a direct blood culture disk diffusion antimicrobial susceptibility test.
Antimicrobial agents and chemotherapy 1981;20(5):696-8.
1981: G V Doern; M J Miller; R E Winn
Branhamella (Neisseria) catarrhalis systemic disease in humans. Case reports and review of the literature.
Archives of internal medicine 1981;141(12):1690-2.
1981: G V Doern; R H Glew; D S Parker; R A Pavuk; S D Brown
Evaluation of a new latex agglutination inhibition card test for determining serum gentamicin levels.
Antimicrobial agents and chemotherapy 1981;19(5):930-3.
1981: R A Fischer; G V Doern; S H Cheeseman
Pseudomonas denitrificans meningitis.
Journal of clinical microbiology 1981;13(5):1004-6.
1980: G V Doern; S A Morse
Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.
Journal of clinical microbiology 1980;11(2):193-5.
1980: G V Doern; K G Siebers; Lesley Marie Hallick; S A Morse
Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
Antimicrobial agents and chemotherapy 1980;17(1):24-9.
1976: G V Doern; F L Buckmire
Ultrastructural characterization of capsulated Haemophilus influenzae type b and two spontaneous nontypable mutants.
Journal of bacteriology 1976;127(1):523-35.